FDA Lifts Partial Clinical Hold on Trial Evaluating NX-2127 in R/R B-Cell Malignancies
The FDA has lifted a partial clinical hold on a phase 1 trial evaluating NX-2127 in relapsed/refractory B-cell malignancies
Source: onclive.com
Page 18 - Collaborative Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Collaborative Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Collaborative Group Today - Breaking & Trending Today
Galloway developer launches new podcast, The Rise, in hopes of inspiring young minds
Mitch Jenkins said he hopes to inspire listeners to "rise to the lives they were created for" through his new project, "The Rise Podcast."
Source: yahoo.com
Study Finds No Protective Benefit against Retinopathy with Omega-3 Fatty Acids
A substudy of the ASCEND trial offers insight into the effects of omega-3 fatty acids use on risk of diabetic retinopathy in people with diabetes.
Source: hcplive.com
Preliminary design unveiled for new memorial at Tree of Life synagogue
A preliminary rendering has been unveiled for the new memorial in the works at Tree of Life synagogue.
Source: yahoo.com
NICE recommends empagliflozin (Jardiance®) for the treatment of adults with chronic kidney disease
The National Institute for Health and Care Excellence (NICE) has issued its Final Draft Guidance (FDG) recommending empagliflozin (Jardiance®) as an option for the treatment of eligible adults with chronic kidney disease (CKD). 1 NICE has applied a streamlined process to this assessment of empagliflozin – an ...
Source: pharmiweb.com